DNA Microarray Analysis of Differential Gene Expression in the Dorsal Root Ganglia of Four Different Neuropathic Pain Mouse Models

References

• Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006;52:77–92. doi:10.1016/j.neuron.2006.09.021
   PubMed Web of Science ®Google Scholar
• Kupfer M, Formal CS. Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain. J Spinal Cord Med. 2020;1–10. doi:10.1080/10790268.2020.1730109
   Web of Science ®Google Scholar
• Kushnarev M, Pirvulescu IP, Candido KD, et al. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers. Expert Opin Investig Drugs. 2020;29:259–271. doi:10.1080/13543784.2020.1728254
   PubMed Web of Science ®Google Scholar
• Lara CO, Burgos CF, Moraga-Cid G, et al. Pentameric ligand-gated ion channels as pharmacological targets against chronic pain. Front Pharmacol. 2020;11:167. doi:10.3389/fphar.2020.00167
   Web of Science ®Google Scholar
• Urru M, Muzzi M, Coppi E, et al. Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models. Pain. 2020;161:831–841. doi:10.1097/j.pain.0000000000001774
   Web of Science ®Google Scholar
• Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;87:149–158. doi:10.1016/s0304-3959(00)00276-1
   PubMed Web of Science ®Google Scholar
• Wall PD, Devor M, Inbal R, et al. Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain. 1979;7:103–111. doi:10.1016/0304-3959(79)90002-2
   PubMed Web of Science ®Google Scholar
• Hirai T, Enomoto M, Kaburagi H, et al. Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury. Mol Ther. 2014;22:409–419. doi:10.1038/mt.2013.247
   PubMed Web of Science ®Google Scholar
• Voinsky I, Bennuri SC, Svigals J, et al. Peripheral blood mononuclear cell oxytocin and vasopressin receptor expression positively correlates with social and behavioral function in children with autism. Sci Rep. 2019;9:13443. doi:10.1038/s41598-019-49617-9
   Web of Science ®Google Scholar
• Rigney N, Beaumont R, Petrulis A. Sex differences in vasopressin 1a receptor regulation of social communication within the lateral habenula and dorsal raphe of mice. Horm Behav. 2020;121:104715. doi:10.1016/j.yhbeh.2020.104715
   Web of Science ®Google Scholar
• Golimbet V, Alfimova M, Abramova L, et al. Arginine vasopressin 1a receptor RS3 promoter microsatellites in schizophrenia: a study of the effect of the “risk” allele on clinical symptoms and facial affect recognition. Psychiatry Res. 2015;225:739–740. doi:10.1016/j.psychres.2014.11.043
   Web of Science ®Google Scholar
• Kordower JH, Bodnar RJ. Vasopressin analgesia: specificity of action and non-opioid effects. Peptides. 1984;5:747–756. doi:10.1016/0196-9781(84)90017-2
   PubMed Web of Science ®Google Scholar
• Peng F, Qu ZW, Qiu CY, et al. Spinal vasopressin alleviates formalin-induced nociception by enhancing GABAA receptor function in mice. Neurosci Lett. 2015;593:61–65. doi:10.1016/j.neulet.2015.03.023
   Web of Science ®Google Scholar
• Bodnar RJ, Wallace MM, Kordower JH, et al. Modulation of nociceptive thresholds by vasopressin in the Brattleboro and normal rat. Ann N Y Acad Sci. 1982;394:735–739. doi:10.1111/j.1749-6632.1982.tb37491.x
   PubMed Web of Science ®Google Scholar
• Schorscher-Petcu A, Sotocinal S, Ciura S, et al. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci. 2010;30:8274–8284. doi:10.1523/JNEUROSCI.1594-10.2010
   Web of Science ®Google Scholar
• Han RT, Kim HB, Kim YB, et al. Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons. Korean J Physiol Pharmacol. 2018;22:173–182. doi:10.4196/kjpp.2018.22.2.173
   Web of Science ®Google Scholar
• Yang J. Intrathecal administration of oxytocin induces analgesia in low back pain involving the endogenous opiate peptide system. Spine (Phila Pa 1976). 1994;19:867–871. doi:10.1097/00007632-199404150-00001
   PubMed Web of Science ®Google Scholar
• Hobo S, Hayashida K, Eisenach JC. Oxytocin inhibits the membrane depolarization-induced increase in intracellular calcium in capsaicin sensitive sensory neurons: a peripheral mechanism of analgesic action. Anesth Analg. 2012;114:442–449. doi:10.1213/ANE.0b013e31823b1bc8
   Web of Science ®Google Scholar
• Sanbe A, Takagi N, Fujiwara Y, et al. Alcohol preference in mice lacking the Avpr1a vasopressin receptor. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1482–1490. doi:10.1152/ajpregu.00708.2007
   PubMed Web of Science ®Google Scholar
• Shir Y, Seltzer Z. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett. 1990;115:62–67. doi:10.1016/0304-3940(90)90518-e
   PubMed Web of Science ®Google Scholar
• Cichon J, Sun L, Yang G. Spared nerve injury model of neuropathic pain in mice. Bio Protoc. 2018;8:e2777. doi:10.21769/bioprotoc.2777
   Web of Science ®Google Scholar
• Rao T, Shao Y, Hamada N, et al. Pharmacokinetic study based on a matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight imaging mass microscope combined with a novel relative exposure approach: a case of octreotide in mouse target tissues. Anal Chim Acta. 2017;952:71–80. doi:10.1016/j.aca.2016.11.056
   PubMed Web of Science ®Google Scholar
• Ponzoni L, Braida D, Bondiolotti G, et al. The non-peptide arginine-vasopressin v1a selective receptor antagonist, SR49059, blocks the rewarding, prosocial, and anxiolytic effects of 3,4-methylenedioxymethamphetamine and its derivatives in zebra fish. Front Psychiatry. 2017;8:146. doi:10.3389/fpsyt.2017.00146
   Web of Science ®Google Scholar
• Vega-Avelaira D, Géranton SM, Fitzgerald M. Differential regulation of immune responses and macrophage/neuron interactions in the dorsal root ganglion in young and adult rats following nerve injury. Mol Pain. 2009;5:70. doi:10.1186/1744-8069-5-70
   Web of Science ®Google Scholar
• Cheng N, Zhang Z, Guo Y, et al. Weighted gene co-expression network analysis reveals specific modules and hub genes related to neuropathic pain in dorsal root ganglions. Biosci Rep. 2019;39. doi10.1042/BSR20191511.
   Web of Science ®Google Scholar
• Mao P, Li CR, Zhang SZ, Zhang Y, Liu BT, Fan BF. Transcriptomic differential lncRNA expression is involved in neuropathic pain in rat dorsal root ganglion after spared sciatic nerve injury. Braz J Med Biol Res. 2018;51:e7113. doi:10.1590/1414-431X20187113
   PubMed Web of Science ®Google Scholar
• Wu S, Marie Lutz B, Miao X, et al. Dorsal root ganglion transcriptome analysis following peripheral nerve injury in mice. Mol Pain. 2016;12. doi:10.1177/1744806916629048
   Web of Science ®Google Scholar
• Diril MK, Ratnacaram CK, Padmakumar VC. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. PNAS. 2012;109(10):3826–3831. doi:10.1037/pnas.1115201109
   PubMed Web of Science ®Google Scholar
• Bagdas D, Yucel-Ozboluk H, Orhan F, et al. Role of central arginine vasopressin receptors in the analgesic effect of CDP-choline on acute and neuropathic pain. Neuroreport. 2013;24:941–946. doi:10.1097/WNR.0000000000000009
   Web of Science ®Google Scholar
• Mogil JS, Sorge RE, LaCroix-Fralish ML, et al. Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nat Neurosci. 2011;14:1569–1573. doi:10.1038/nn.2941
   Web of Science ®Google Scholar
• Alvarez de la Rosa D, Zhang P, Shao D, et al. Functional implications of the localization and activity of acid-sensitive channels in rat peripheral nervous system. Proc Natl Acad Sci U S A. 2002;99:2326–2331. doi:10.1073/pnas.042688199
   PubMed Web of Science ®Google Scholar
• Qiu F, Hu WP, Yang ZF. Enhancement of GABA-activated currents by arginine vasopressin in rat dorsal root ganglion neurons. Sheng Li Xue Bao. 2014;66:647–657. doi:10.13294/j.aps.2014.0077
   Google Scholar
• Qiu F, Qiu CY, Cai H, et al. Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons. Br J Pharmacol. 2014;171:3065–3076. doi:10.1111/bph.12635
   Web of Science ®Google Scholar
• Kubo A, Shinoda M, Katagiri A, et al. Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia. Pain. 2017;158:649–659. doi:10.1097/j.pain.0000000000000808
   PubMed Web of Science ®Google Scholar
• Bodnar RJ, Nilaver G, Wallace MM, et al. Pain threshold changes in rats following central injection of beta-endorphin, met-enkephalin, vasopressin or oxytocin antisera. Int J Neurosci. 1984;24:149–160. doi:10.3109/00207458409089803
   Web of Science ®Google Scholar
• Madrazo I, Franco-Bourland RE, León-Meza VM, et al. Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain. Appl Neurophysiol. 1987;50:427–431. doi:10.1159/000100753
   PubMedGoogle Scholar
• Watkins LR, Suberg SN, Thurston CL, et al. Role of spinal cord neuropeptides in pain sensitivity and analgesia: thyrotropin releasing hormone and vasopressin. Brain Res. 1986;362:308–317. doi:10.1016/0006-8993(86)90455-5
   Web of Science ®Google Scholar
• Thurston CL, Culhane ES, Suberg SN, et al. Antinociception vs motor effects of intrathecal vasopressin as measured by four pain tests. Brain Res. 1988;463:1–11. doi:10.1016/0006-8993(88)90520-3
   Web of Science ®Google Scholar
• Thurston CL, Campbell IG, Culhane ES, et al. Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression. Peptides. 1992;13:17–25. doi:10.1016/0196-9781(92)90135-p
   Web of Science ®Google Scholar
• Manzano-García A, González-Hernández A, Tello-García IA, et al. The role of peripheral vasopressin 1A and oxytocin receptors on the subcutaneous vasopressin antinociceptive effects. Eur J Pain. 2018;22:511–526. doi:10.1002/ejp.1134
   Web of Science ®Google Scholar